CAS: 27219-07-4; Boc-5-Ava-Oh

该化合物是一种受保护的氨基酸衍生物,配有四氨基丁氧碳酸基(Boc)组,附于四氨基丁基酸脊椎,该化合物作为一种构件,广泛用于浸泡物合成,为矿山功能提供选择性保护,同时将碳箱基组留给混合反应使用.Boc组在基本条件下提供稳定性,可以在酸性条件下轻易去除,使其适合正向保护战略.它与标准的固相聚聚聚苯乙烯合成(SPPS)议定书的一致再活动性和兼容性增强了其在生产复杂的聚醚和经修改的生物分子方面的效用.

结构式图片

相似化合物

123622-48-0 660-88-8 23135-50-4

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号24424-99-5 二碳酸二叔丁酯 | CAS号660-88-8 5-氨基戊酸 | CAS号74651-77-7 (E)-N-((tert-Bu... | CAS号85908-96-9 1-B°C-2-哌啶酮 | CAS号34619-03-9 碳酸二叔丁酯 | CAS号41840-28-2 S-B°C-2-巯基-4,6-二甲基嘧啶 | CAS号497-19-8 纯碱 | CAS号675-20-7 2-氮己环酮 | CAS号51644-96-3 N-(5-氨基戊基)氨基甲酸叔丁酯 | CAS号83948-54-3 5-(t-B°C-氨基)-1-戊基溴化物 | CAS号660-88-8 5-氨基戊酸 | CAS号75178-90-4 5-(叔丁氧羰氨基)-1-戊醇 | CAS号2446-62-0 8,9-二氢-6H-吡啶并[2... | CAS号88313-82-0 S-(5-aminopenty... | CAS号91419-47-5 tert-butyl N-(5... | CAS号60811-47-4 2-chloro-6,7,8,...

合成工艺路线路线简述

  • 合成目标产物 Boc-5-Aminopentanoic Acid 主要起始原料 Di-Tert-Butyl Dicarbonate And 5-Aminovaleric Acid
  • (文献来源)合成步骤主要原料 Di-Tert-Butyl Dicarbonate 和 5-Aminovaleric Acid
1-Boc-2-哌啶酮置于lithium Hydroxide体系中,用 四氢呋喃 用作溶剂,化学反应 0.5H,以90%的收率获得boc-5-氨基戊酸
参考文献:A Mild Two-Step Method For The Hydrolysis Of Lactams And Secondary Amides
标题:A Mild Two-Step Method For The Hydrolysis Of Lactams And Secondary Amides
摘要:
Doi:10.1021/jo00162A028

海关参考信息

专利信息


专利号:US-2004110228-A1
优先权日:2002-04-01
标 题:Combinatorial organic synthesis of unique biologically active compounds
发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

专利号:US-2023295613-A1
优先权日:2020-02-14
标 题:Long chain carbon and cyclic amino acids substrates for genetic code reprogramming
发明人:JEWETT MICHAEL C; LEE JOONGOO; MOORE JEFFREY S; SCHWARZ KEVIN J
权利人:UNIV NORTHWESTERN; UNIV ILLINOIS
摘要:Abstract: Disclosed are methods, systems, components, and compositions for synthesis of sequence defined polymers. The methods, systems, components, and compositions may be utilized for incorporating novel substrates that include non-standard amino acid monomers and non-amino acid monomers into sequence defined polymers. As disclosed herein, the novel substrates may be utilized for acylation of tRNA via flexizyme catalyzed reactions. The tRNAs thus acylated with the novel substrates may be utilized in synthesis platforms for incorporating the novel substrates into a sequence defined polymer.

专利号:US-11814621-B2
优先权日:2018-06-01
标题 :Expanding the chemical substrates for genetic code reprogramming
发明人:JEWETT MICHAEL CHRISTOPHER; LEE JOONGOO; MOORE JEFFREY S; SCHWIETER KENNETH E; SCHWARZ KEVIN JEROME
权利人:UNIV NORTHWESTERN; UNIV ILLINOIS
摘要:Disclosed are methods, systems, components, and compositions for synthesis of sequence defined polymers. The methods, systems, components, and compositions may be utilized for incorporating novel substrates that include non-standard amino acid monomers and non-amino acid monomers into sequence defined polymers. As disclosed herein, the novel substrates may be utilized for acylation of tRNA via flexizyme catalyzed reactions. The tRNAs thus acylated with the novel substrates may be utilized in synthesis platforms for incorporating the novel substrates into a sequence defined polymer.

专利号:US-8475998-B2
优先权日:2010-12-20
标 题 :Compound synthesis method, microarray, acid-transfer composition, and biochip composition
发明人:YUN HYOJIN; YOO CHANGEUN; KIM MYUNG-SUN; KIM SOO-KYUNG; NISHIKAWA KOUJI; GOTO HIROFUMI; MIYAMOTO HIDETOSHI
权利人:YUN HYOJIN; YOO CHANGEUN; KIM MYUNG-SUN; KIM SOO-KYUNG; NISHIKAWA KOUJI; GOTO HIROFUMI; MIYAMOTO HIDETOSHI; SAMSUNG ELECTRONICS CO LTD; JSR CORP
摘要:A compound synthesis method includes bonding a first compound to a substrate to form a first film. A second film is formed on the first film using an acid-transfer composition including (A) a polymer that includes a structural unit shown by a following formula (1) and a structural unit shown by a following formula (2), (B) a photoacid generator shown by a following formula (3), and (C) a sensitizer shown by a following formula (4). The second film is exposed to remove the protecting group from the first compound under an exposed area of the second film. An acid generated in the exposed area of the second film is transferred to the first film. The second film after being exposed is removed. A second compound is bonded to the first compound from which the protecting group has been removed.

专利号:US-5916899-A
优先权日:1996-10-18
标 题:Isoquinoline derivatives and isoquinoline combinatorial libraries
发明人:KIELY JOHN S; GRIFFITH MICHAEL C
权利人:TREGA BIOSCIENCES INC
摘要:The present invention provides the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinolines as well as novel libraries comprised of many such compounds, and methods of synthesizing the libraries.

专利号:US-6407103-B2
优先权日:1998-04-21
标 题:Indeno [1,2-c] pyrazol-4-ones and their uses
发明人:NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; YUE EDDY W
权利人:BRISTOL MYERS SQUIBB PHARMA CO
摘要:The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.
连云港科联化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.klinechem.com
企业联系👤
📞连云港科联化工有限公司 ⚠️参考联系方式
联系人:李先生

手机:86-18014602686
传真:86-518-88103267
邮箱:sales@klinechem.com
通信地址: 江苏省连云港市灌云县临港产业区纬五路经七路
邮编: 222000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省连云港市灌云县临港产业区纬五路经七路
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]:Hsu Jh, Et Al. Eed-Targeted Protacs Degrade Eed, Ezh2, And Suz12 In The Prc2 Complex. Cell Chem Biol. 2019 Nov 26. Pii: S2451-9456(19)30362-9.

合成参考文献


摘要:Wietelmann, U., Science of Synthesis, (2006) 8, 165.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知